Source: FinanzNachrichten

Vedanta: Vedanta Biosciences' Key Microbiome Patents Fully Upheld in Three European Opposition Proceedings

The three patents broadly cover therapeutic compositions of clostridial bacteria derived from the human microbiome and their uses in infectious disease, allergy, and autoimmune disease Vedanta's c...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Bernat Olle's photo - Co-Founder & CEO of Vedanta

Co-Founder & CEO

Bernat Olle

CEO Approval Rating

84/100

Read more